Suppr超能文献

关于绿茶儿茶素安全性的科学意见。

Scientific opinion on the safety of green tea catechins.

作者信息

Younes Maged, Aggett Peter, Aguilar Fernando, Crebelli Riccardo, Dusemund Birgit, Filipič Metka, Frutos Maria Jose, Galtier Pierre, Gott David, Gundert-Remy Ursula, Lambré Claude, Leblanc Jean-Charles, Lillegaard Inger Therese, Moldeus Peter, Mortensen Alicja, Oskarsson Agneta, Stankovic Ivan, Waalkens-Berendsen Ine, Woutersen Rudolf Antonius, Andrade Raul J, Fortes Cristina, Mosesso Pasquale, Restani Patrizia, Arcella Davide, Pizzo Fabiola, Smeraldi Camilla, Wright Matthew

出版信息

EFSA J. 2018 Apr 18;16(4):e05239. doi: 10.2903/j.efsa.2018.5239. eCollection 2018 Apr.

Abstract

The EFSA ANS Panel was asked to provide a scientific opinion on the safety of green tea catechins from dietary sources including preparations such as food supplements and infusions. Green tea is produced from the leaves of (L.) Kuntze, without fermentation, which prevents the oxidation of polyphenolic components. Most of the polyphenols in green tea are catechins. The Panel considered the possible association between the consumption of (-)-epigallocatechin-3-gallate (EGCG), the most relevant catechin in green tea, and hepatotoxicity. This scientific opinion is based on published scientific literature, including interventional studies, monographs and reports by national and international authorities and data received following a public 'Call for data'. The mean daily intake of EGCG resulting from the consumption of green tea infusions ranges from 90 to 300 mg/day while exposure by high-level consumers is estimated to be up to 866 mg EGCG/day, in the adult population in the EU. Food supplements containing green tea catechins provide a daily dose of EGCG in the range of 5-1,000 mg/day, for adult population. The Panel concluded that catechins from green tea infusion, prepared in a traditional way, and reconstituted drinks with an equivalent composition to traditional green tea infusions, are in general considered to be safe according to the presumption of safety approach provided the intake corresponds to reported intakes in European Member States. However, rare cases of liver injury have been reported after consumption of green tea infusions, most probably due to an idiosyncratic reaction. Based on the available data on the potential adverse effects of green tea catechins on the liver, the Panel concluded that there is evidence from interventional clinical trials that intake of doses equal or above 800 mg EGCG/day taken as a food supplement has been shown to induce a statistically significant increase of serum transaminases in treated subjects compared to control.

摘要

欧洲食品安全局(EFSA)的食品添加剂和营养源添加物专家委员会(ANS Panel)被要求就包括食品补充剂和冲泡饮品等膳食来源的绿茶儿茶素的安全性提供科学意见。绿茶由茶(.)的叶子制成,未经发酵,这可防止多酚成分氧化。绿茶中的大多数多酚都是儿茶素。该专家委员会考虑了绿茶中最主要的儿茶素(-)-表没食子儿茶素-3-没食子酸酯(EGCG)的摄入与肝毒性之间的可能关联。本科学意见基于已发表的科学文献,包括干预性研究、国家和国际权威机构的专著及报告,以及在公开的“数据征集”之后收到的数据。在欧盟成年人群体中,饮用绿茶冲泡饮品导致的EGCG平均每日摄入量为90至300毫克/天,而高摄入量消费者的暴露量估计高达866毫克EGCG/天。含绿茶儿茶素的食品补充剂为成年人群体提供的EGCG每日剂量在5至1000毫克/天范围内。该专家委员会得出结论,按照安全性推定方法,以传统方式制备的绿茶冲泡饮品以及成分与传统绿茶冲泡饮品相当的复原饮品,一般被认为是安全的,前提是摄入量与欧洲成员国报告的摄入量相符。然而,饮用绿茶冲泡饮品后有罕见的肝损伤病例报告,很可能是由于特异反应。基于关于绿茶儿茶素对肝脏潜在不良影响的现有数据,该专家委员会得出结论,干预性临床试验的证据表明,作为食品补充剂摄入等于或高于800毫克EGCG/天的剂量,与对照组相比,已显示治疗受试者的血清转氨酶有统计学显著升高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19cd/7009618/2e46095747e9/EFS2-16-e05239-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验